Visit COVID-19 resources

[Skip to Content]

Eye Journal

Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ – (Eye Journal AOP)

Feb 12
2016

Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ Eye advance online publication, February 12 2016. doi:10.1038/eye.2016.6 Authors: T D Papakostas, D Vavvas, D Eliott & L A Kim

  • 12 February 2016

Post-traumatic endophthalmitis in 143 eyes of children and adolescents from India – (Eye Journal AOP)

Feb 12
2016

Post-traumatic endophthalmitis in 143 eyes of children and adolescents from India Eye advance online publication, February 12 2016. doi:10.1038/eye.2016.9 Authors: E Rishi, P Rishi, V V Koundanya, C Sahu, R Roy & P S Bhende

  • 12 February 2016

Intraoperative optical coherence tomography: past, present, and future – (Eye 30, 193 (February 2016))

Feb 11
2016

Intraoperative optical coherence tomography: past, present, and future Eye 30, 193 (February 2016). doi:10.1038/eye.2015.255 Author: J P Ehlers

  • 11 February 2016

Photodynamic therapy: current role in the treatment of chorioretinal conditions – (Eye 30, 202 (February 2016))

Feb 11
2016

Photodynamic therapy: current role in the treatment of chorioretinal conditions Eye 30, 202 (February 2016). doi:10.1038/eye.2015.251 Author: D K Newman

  • 11 February 2016

Light in man’s environment – (Eye 30, 211 (February 2016))

Feb 11
2016

Light in man’s environment Eye 30, 211 (February 2016). doi:10.1038/eye.2015.265 Author: J Marshall

  • 11 February 2016